Searchable abstracts of presentations at key conferences in endocrinology

ea0086p243 | Neuroendocrinology and Pituitary | SFEBES2022

Imaging surveillance of completely resected gastroenteropancreatic neuroendocrine tumors is associated with high levels of radiation exposure

Ianuzzi Jordan , Yeo Caitlin , Parkins Vicky , Pasieka Janice , Ruether Dean , Chan Denise , Albalawi Zaina , Stewart Errol , Lithgow Kirstie

Background & Aims: Neuroendocrine tumours (NET) are a heterogenous group of neoplasms that secrete peptides and neuroamines. For potentially malignant gastroenteropancreatic (GEP) NET, surgical resection represents the only curative option. Ten-year imaging surveillance programs using cross sectional imaging are recommended due to long time-to-recurrence following resection. We performed a retrospective chart review to evaluate radiation exposure associated with surveillan...

ea0070aep866 | Thyroid | ECE2020

Radioactive Iodine-Refractory (RAI) Differentiated Thyroid Cancer (rDTC): Analysis of the Canadian Patient Support Program (PSP) for the Prescription and Treatment Patterns of Lenvatinib (LEN)

Boucher Andree , Hortensia Mircescu , Geneviève Rondeau , Rebecca Leboeuf , Bernard Lemieux , Maryse Brassard , Marie-Hélène Massicotte , monika Krzyzanowska , Dean Ruether , Nathaniel Bouganim , Nathan Lamond , Shereen Ezzat , Eric Winquist , Scott Laurie , Neil Chua , Paul Klimo , Howard Lim , Ralph Wong , Ramji Zahra , Alexander Flint , Hauck Wendy , Sebastien Hotte

Differentiated thyroid carcinoma (DTC) is viewed as an indolent disease but 5–15% of patients (pts) become refractory to RAI treatment. This is associated with poor prognosis, a 3–6 years life expectancy and accounts for approximately 200 deaths per year in Canada. There is no universal definition of rDCT and management evolves over time, with either monitoring or systemic therapy including LEN. In the Select Study on LEN in DTC, LEN provided a 19.4 month (mo) medi...